FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
This Quarter Return
+5.37%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
–
10 Year Return
–
AUM
$1.5B
AUM Growth
-$170M
(-10%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
63.15%
Holding
55
New
7
Increased
10
Reduced
5
Closed
4
Top Buys
| 1 |
Mirum Pharmaceuticals
MIRM
|
$66.7M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$28.7M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$23.4M |
| 4 |
AN2 Therapeutics
ANTX
|
$22.3M |
| 5 |
BridgeBio Pharma
BBIO
|
$19.4M |
Top Sells
Sector Composition
| 1 | Healthcare | 99.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$64M
| $951K | 0.06% |
500,333
| – | – |
|
52
Immunovant
IMVT
$2.91B
| – | – |
-300,000
| Closed | -$5.69M |
|
|
MORF
53
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-265,511
| Closed | -$15.2M |
|
|
RETA
54
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – |
-100,430
| Closed | -$10.2M |
|
|
KDNY
55
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-4,345,559
| Closed | -$167M |
|